Allogenic adipose derived stem cells present a potential novel approach for treating refractory fistulizing Crohn's disease

Turk J Gastroenterol. 2016 Nov;27(6):568-569. doi: 10.5152/tjg.2016.160008.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Crohn Disease*
  • Gastrointestinal Agents*
  • Humans
  • Infliximab
  • Intestinal Fistula
  • Stem Cells
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab